Registry for adults with certain BCR-ABL1–negative blood cancers
Part of Blood & lymphatic, Cancer clinical trials.
This study keeps a patient registry to collect information about people with specific myeloid blood neoplasms (a type of blood cancer). It helps researchers understand these conditions over time and may improve how patients are cared for in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (no upper age limit).
- You have a diagnosis of BCR-ABL1–negative myeloid neoplasia as defined by the study criteria.
- You can and will sign informed consent to join the registry.
- You do not have a severe brain (neurological) or mental health (psychiatric) condition that would prevent you from understanding consent.
- You agree to have your personal information registered, stored, and used for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
This study enrolls adults with acute myeloid leukemia (AML) to build a detailed registry and store biological samples. It helps researchers understand AML better and may support future studies.
This is a registry study that collects information from people with myeloid blood diseases. It helps researchers better understand these conditions and support future research.
This study tracks children and teens with certain rare blood cancers called myeloproliferative neoplasms (MPNs). By collecting information from many patients, doctors hope to better understand these conditions and improve care for young people.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
This is a research registry for people who have certain blood cancers called myeloproliferative neoplasms (MPNs). It helps researchers learn about the disease over time and may help future studies find and compare patients.
Hear when a new BCR-ABL1-Negative Myeloid Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.